A hypothesis for the molecular mechanism of action of chlorpropamide in the treatment of diabetes mellitus and diabetes insipidus.
D000818:Animals; D001001:Anura; D002747:Chlorpropamide / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004285:Dogs; D006801:Humans; D011458:Prostaglandins E / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D001743:Urinary Bladder / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology
D011458:Prostaglandins E; D014667:Vasopressins; D002747:Chlorpropamide